Friday, May 15, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

BrainChip Secures Key Licensing Agreement for Akida-2 Technology

Rodolfo Hanigan by Rodolfo Hanigan
March 31, 2026
in AI & Quantum Computing, Semiconductors, Tech & Software, Trading & Momentum
0
BrainChip Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

The neuromorphic computing specialist BrainChip has announced a significant commercial milestone, signaling a potential turnaround after a prolonged period of limited news. The company entered into a global licensing agreement with EDGEAI over the weekend, granting access to its next-generation Akida-2 technology. This deal reinforces a fundamental recovery that was initially hinted at in the firm’s latest annual revenue figures.

Under the terms of the non-exclusive partnership, EDGEAI receives comprehensive access to the intellectual property underpinning BrainChip’s Akida architecture. The agreement also includes necessary development tools and software components. Financial returns for BrainChip will come through milestone-based payments linked to technical delivery targets. Once EDGEAI begins commercial shipment of its own products, quarterly royalty payments will commence. While management has not yet quantified the precise financial scope, it anticipates substantial long-term revenue streams from resulting product sales.

Should investors sell immediately? Or is it worth buying BrainChip?

Financial Performance Shows Marked Improvement

This new contract aligns with a broader positive shift in the company’s financial trajectory. The annual report for 2025, published in late February, revealed a dramatic 374 percent surge in revenue to $1.89 million. Concurrently, BrainChip managed to narrow its net loss from $24.43 million to $20.47 million. The company also strengthened its balance sheet, with cash reserves growing to $31.71 million. Investor sentiment has responded with cautious optimism. The equity, currently trading at €0.09, is attempting to stabilize following an approximate 28 percent decline over the preceding twelve-month period.

Operational Milestones on the Horizon

Beyond commercial deals, operational execution is now coming into focus. The company reports that its AKD1500 chip has entered the volume production phase, with final silicon expected in the third quarter of 2026. In parallel, development has commenced on the custom AKD2500 project. First prototypes for this chip are also slated for availability in Q3 2026. These technological advancements form the foundation for BrainChip to more broadly address rising demand for ultra-low-power AI applications within the edge computing sector.

Ad

BrainChip Stock: Buy or Sell?! New BrainChip Analysis from May 15 delivers the answer:

The latest BrainChip figures speak for themselves: Urgent action needed for BrainChip investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 15.

BrainChip: Buy or sell? Read more here...

Tags: BrainChip
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Alphabet Stock
AI & Quantum Computing

Alphabet’s $3.6 Billion Samurai Bond and Cloud Surge Signal Confidence in AI Bet

May 15, 2026
Palantir Stock
AI & Quantum Computing

Palantir’s Record Quarter Meets a Wall of Worry: Yields, Valuation, and Insider Sales Eclipse a Ukraine Showcase

May 14, 2026
AMD Stock
AI & Quantum Computing

AMD’s Product Blitz: Ryzen Pro 9000 and Helios Racks Target a Trillion-Dollar Arena as Earnings Momentum Builds

May 14, 2026
Next Post
Nexus Uranium Stock

Nexus Uranium Shifts Focus to Project Exploration Following Strategic Acquisitions

Orsted Stock

Bank of America Upgrade Ignites Surge in Ørsted Shares

Roche Stock

Roche's Diagnostic Division Gains Momentum with Dual Regulatory Wins

Recommended

Nel ASA Stock

Nel ASA Shares Surge on Major Hydrogen Contracts

6 months ago
Eutelsat Stock

Eutelsat Consolidates Brand Identity to Drive Next Growth Chapter

8 months ago
Matson Stock

Matson’s Capital Efficiency Shows Strong Recovery Amid Mixed Quarterly Results

9 months ago
AMD Stock

AMD’s Strategic Push to Challenge AI Market Leadership

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Alphabet’s $3.6 Billion Samurai Bond and Cloud Surge Signal Confidence in AI Bet

Oracle’s Samsung Java Win Provides Steady Revenue Backdrop for $50 Billion AI Buildout

Palantir’s Record Quarter Meets a Wall of Worry: Yields, Valuation, and Insider Sales Eclipse a Ukraine Showcase

Ondas Draws Blue-Chip Investors Even as Short Sellers Circle Ahead of Q1 Earnings

QuantumScape Bears Squeezed as Production Ramp and Earnings Beat Provide Dual Catalyst

IonQ’s Blazing Revenue Growth Collides with FTC Roadblock on $1.8B SkyWater Takeover

Trending

AMD Stock

AMD Courts Samsung for 2nm Chips as Server Dominance Forces Intel Into a Corner

by Rodolfo Hanigan
May 15, 2026
0

Advanced Micro Devices is pushing deeper into the server market while simultaneously expanding its manufacturing base, with...

Ocugen Stock

Ocugen Halves Interest Expense as $130M Convertible Refinances High-Cost Debt

May 15, 2026
OHB SE Stock

From Venus to Defense: OHB Posts Record Backlog and Doubled Earnings Amid Strategic Reassurance

May 15, 2026
Alphabet Stock

Alphabet’s $3.6 Billion Samurai Bond and Cloud Surge Signal Confidence in AI Bet

May 15, 2026
Oracle Stock

Oracle’s Samsung Java Win Provides Steady Revenue Backdrop for $50 Billion AI Buildout

May 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AMD Courts Samsung for 2nm Chips as Server Dominance Forces Intel Into a Corner
  • Ocugen Halves Interest Expense as $130M Convertible Refinances High-Cost Debt
  • From Venus to Defense: OHB Posts Record Backlog and Doubled Earnings Amid Strategic Reassurance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com